Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Duvyzat™ (givinostat) – New orphan drug approval
March 21, 2024 - The FDA announced the approval of Italfarmaco’s Duvyzat (givinostat), for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
